Antioxidant activity of BO-653 in orally administered healthy subjects (phase I study)

被引：0
作者：
Mashima, R
Ray, S
O'Halloran, R
Kawabe, Y
Komori, T
Cynshi, O
Stocker, R
机构：
[1] Heart Res Dev PL, Camperdown, NSW 2050, Australia
[2] Heart Res Inst, Camperdown, NSW 2050, Australia
[3] Chugai Pharmaceut Co Ltd, Shizuoka, Japan
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2002年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
371
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [21] Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer
    Jan C. Buckner
    Bahram Forouzesh
    Charles Erlichman
    Manuel Hidalgo
    Joseph P. Boni
    Gary Dukart
    Anna Berkenblit
    Eric K. Rowinsky
    Investigational New Drugs, 2010, 28 : 334 - 342
  • [22] PHARMACOKINETICS OF ORALLY-ADMINISTERED HEXOBARBITAL IN PLASMA AND SALIVA OF HEALTHY-SUBJECTS
    VANDERGRAAFF, M
    VERMEULEN, NPE
    HEIJ, P
    BOEIJINGA, JK
    BREIMER, DD
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (03) : 265 - 272
  • [23] The effect of orally administered dronabinol on ocular blood flow parameters in healthy subjects
    Schmidl, Doreen
    Hommer, Nikolaus
    Kallab, Martin
    Bauer, Martin
    Werkmeister, Rene M.
    Schmetterer, Leopold
    Garhoefer, Gerhard
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (08) : A160 - A160
  • [24] THE EFFECTS OF ORALLY ADMINISTERED UREA ON HEALTHY SUBJECTS AND THEIR GASTRIC SECRETORY RESPONSE TO HISTAMINE
    BURKE, JO
    PAGE, SG
    GASTROENTEROLOGY, 1954, 26 (03) : 503 - 505
  • [25] PHARMACOKINETICS OF VIBUNAZOLE (BAY N 7133) ADMINISTERED ORALLY TO HEALTHY-SUBJECTS
    VANGULPEN, C
    KELDER, O
    MATTIE, H
    VANDERMEER, JWM
    VANTWOUT, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (01) : 75 - 79
  • [26] Photoreaction (PR) potential of orally administered levofloxacin (LVFX) in healthy subjects.
    Boccumini, L
    Fowler, C
    Campbell, T
    Puertolas, L
    Kaidbey, K
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 291 - 291
  • [27] Enhancement of NK cell activity and Th1 immunity in healthy subjects by orally administered fucoidan mix
    Miyazaki, Yoshiyuki
    Nakamizo, Masaji
    Tsuji, Hiromitsu
    Kirino, Tomomi
    Saito, Yuzu
    Kawahara, Kazuhiro
    Otsuka, Ken
    Tachibana, Hirofumi
    Yamada, Koji
    Fujii, Makoto
    Tachikawa, Daisuke
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [28] Effect of Itraconazole or Rifampin on Itacitinib Pharmacokinetics When Administered Orally in Healthy Subjects
    Barbour, April M.
    Punwani, Naresh
    Epstein, Noam
    Landman, Robert
    Cimino, Evan
    Yuska, Brad
    Wang, Phillip
    He, Kevin
    Chen, Xuejun
    Yeleswaram, Swamy
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (12) : 1641 - 1647
  • [29] Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects
    Tomaru, Atsuko
    Takeda-Morishita, Mariko
    Maeda, Kazuya
    Banba, Hirokazu
    Takayama, Kozo
    Kumagai, Yuji
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (03) : 221 - 226
  • [30] SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF A SINGLE ORALLY ADMINISTERED DOSE OF ENPATORAN IN A PHASE I STUDY OF HEALTHY JAPANESE AND CAUCASIAN PARTICIPANTS
    Gopalakrishnan, S.
    Krebs-Brown, A.
    Nogueira Filho, M.
    Kuroki, Y.
    Bachmann, A.
    Becker, A.
    Schippers, F.
    Fluck, M.
    Yalkinoglu, O.
    Klopp-Schulze, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 663 - 664
12345